South and Central America Cancer Radiation Therapy Market Outlook (2021–2031)

Increasing Occurrence of Cancer

Cancer incidence is rising across South and Central America due to population aging, urbanization, and lifestyle-related risk factors such as smoking, unhealthy diets, and reduced physical activity. Breast, prostate, colorectal, and cervical cancers are among the most prevalent in countries such as Brazil, Argentina, Mexico, and Colombia. Improved awareness and expanding screening programs have led to higher detection rates, increasing the number of patients requiring radiation therapy as part of comprehensive cancer care.

Healthcare infrastructure in the region varies widely, with urban centers equipped with modern oncology facilities while rural areas often face limited access. External beam radiation therapy is the predominant modality due to its versatility in treating multiple tumor types, while internal beam therapy is used for prostate, cervical, and gynecological cancers. This growing patient load is prompting hospitals to expand radiation oncology capacity and upgrade equipment.

Governments and private healthcare providers are investing in oncology infrastructure to manage the increasing cancer burden. Public - private partnerships and collaborations with international institutions are helping improve access to advanced treatment technologies. As cancer prevalence continues to rise, it remains a strong driver for sustained growth in the South and Central American cancer radiation therapy market.

The Increasing Appeal of Customized Healthcare

Personalized medicine is emerging as a key trend in South and Central America, driven by the need to improve treatment outcomes and reduce side effects. Radiation therapy is tailored to individual patients based on tumor characteristics, location, and patient-specific factors. This trend is fostering the adoption of advanced external beam techniques such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT).

Internal beam radiation therapy is also becoming more personalized, particularly for prostate, cervical, and gynecological cancers, where precise dose delivery significantly improves outcomes. Leading hospitals in Brazil, Argentina, and Mexico are integrating AI-assisted planning and advanced imaging tools to optimize therapy for individual patients.

Collaboration with international technology providers and training initiatives is enhancing the capability of regional cancer centers to deliver customized radiation therapy. Patients are becoming more informed and actively seek high-quality treatments that minimize side effects. This rising demand for personalized care creates substantial opportunities for equipment manufacturers, software developers, and healthcare systems across the South and Central American cancer radiation therapy market.

The "South and Central America Cancer Radiation Therapy Market Size and Forecast (2021 - 2031)" report provides a detailed analysis of the market covering below areas:

• South and Central America Cancer Radiation Therapy market size and forecast at regional and country levels for market segments covered under the scope
• South and Central America Cancer Radiation Therapy market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• South and Central America Cancer Radiation Therapy market analysis covering key market trends, regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the South and Central America Cancer Radiation Therapy market
• Detailed company profiles, including SWOT analysis

The geographical scope of the South and Central America Cancer Radiation Therapy market report is divided into: Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. Brazil held the largest share in 2024.

Brazil dominates the South and Central America cancer radiation therapy market due to its extensive oncology infrastructure, concentration of advanced treatment centers, and well-trained clinical workforce. Major cities such as São Paulo, Rio de Janeiro, and Brasília host a majority of high-technology radiotherapy facilities, including linear accelerators, IMRT, IGRT, stereotactic radiotherapy, and brachytherapy units. Hospitals and cancer centers in Brazil integrate radiotherapy with multidisciplinary care, ensuring comprehensive treatment approaches for complex cases.

The country's leadership is reinforced by continuous investment in equipment modernization, research initiatives, and digital oncology platforms, which enhance treatment planning, patient management, and workflow efficiency. Brazil also benefits from structured training programs for radiation oncologists, physicists, and technologists, ensuring expertise in advanced radiotherapy modalities. Its position as a regional oncology hub attracts patients from neighboring countries seeking high-quality care. Combined infrastructure, clinical expertise, and strategic investment initiatives consolidate Brazil's dominance in South and Central America's cancer radiation therapy market.

• The report includes qualitative and quantitative data in the South and Central America cancer radiation therapy market across type, cancer type, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the South and Central America Cancer Radiation Therapy market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the South and Central America Cancer Radiation Therapy market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the South and Central America Cancer Radiation Therapy market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 10 cover South and Central America Cancer Radiation Therapy market segments by type, cancer type, end user, and geography across Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. They cover the market revenue, forecast, and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the South and Central America Cancer Radiation Therapy market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The South and Central America Cancer Radiation Therapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the South and Central America cancer radiation therapy market are:

• In May 2024, Elekta announced the launch of its latest linear accelerator system, Evo, featuring AI‑enhanced imaging and online/offline adaptive radiotherapy capabilities, aimed at improving the precision and flexibility of radiation therapy delivery, a development highlighted as relevant to expanding advanced radiotherapy technology adoption across markets, including South & Central America.
• In May 2024, GE HealthCare announced the launch of Revolution RT radiation therapy CT solution, designed to increase imaging accuracy and improve simulation workflows for oncologists, a product initiative noted for its applicability to radiotherapy treatment pathways in South & Central America.